Medpacto

Company developing ALK-5 kinase inhibitors for treating solid tumors and multiple myeloma

placeSuwon-si, Gyeonggi-do, South Korea calendar_todayFounded 2013 groups62 employees language medpacto.com

Innovation

20 patent families (9 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady.

Coming soon